TASSO PARTNERS, LLC enters PAVMED INC. with 913K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/7/2026ACC: 0001094891-26-000168
913K
Baseline shares
100% direct
913K
Direct ownership
1 position
5.37K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned913K
Total
913K direct913K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 913K | Direct |
| Total | 913K | 913K direct |
Derivative Holdings1
Warrants
DirectUnderlying security
Series D Preferred Stock
Underlying shares
5.37K
Shares owned
N/A
Exercise price
1000
Expiration
—
Exercise window
—
Total
Underlying
5.37K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Direct | Series D Preferred Stock | 1000 | — | — | 5.37K | N/A |
| Total | 5.37K | 0.00 | ||||